Scarica l'app Stockscreener
1.99
2.93%
-0.06
Pre-mercato:
1.93
-0.06
-3.02%
Nuwellis Inc Borsa (NUWE) Ultime notizie
Nuwellis appoints Mike McCormick CEO effective June 30 - scanx.trade
Nuwellis reports 14% second-quarter revenue growth - grafa.com
Nuwellis, Inc. Provides Unaudited Preliminary Results for Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nuwellis reports 14% revenue growth in Q2 2026, driven by Aquadex platform momentum. - Pluang
Nuwellis Q2 Results: Revenue up 14% YoY, H2 growth hits 20% - scanx.trade
Nuwellis reports 14% revenue growth in second quarter 2026 - Investing.com
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth - The Manila Times
Nuwellis Announces Preliminary Revenue Results For The Second Quarter 2026 Showing Double Digit Growth - TradingView
Nuwellis’ new CEO on building a strong foundation for sustainable value creation - Yahoo Finance
Nuwellis Inc (NUWE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Nuwellis, Inc. Revenue Breakdown – NASDAQ:NUWE - TradingView
NUWE|Nuwellis Inc|Price:2.000|Chg%:-0.050 - TradingKey
TradingKey - TradingKey
NUWE|Nuwellis Inc|Price:2.050|Chg%:-0.150 - TradingKey
Nuwellis, Inc. Proposes Reverse Stock Split to Maintain Nasdaq Listing – SEC Form 8-K Filing July 2026 - Minichart
Nuwellis Shareholders Approve Reverse Stock Split Authorization - TipRanks
Nuwellis Inc (NUWE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Nuwellis Inc. (NUWE) Rallies 5.26% as Stock Tests Key ResistanceBPI Bull Correction - dars.gov.et
Nuwellis secures new US patent for dual-lumen catheter technology - MSN
NUWE News | NUWELLIS INC (NASDAQ:NUWE) - ChartMill
Nuwellis receives patent for dual lumen catheter technology By Investing.com - Investing.com Nigeria
Nuwellis awarded U.S. patent for Dual Lumen Catheter - TipRanks
Nuwellis wins U.S. patent for a catheter that i... - Pluang
Nuwellis (NUWE) Secures Patent for Innovative Catheter Technology - GuruFocus
Nuwellis receives patent for dual lumen catheter technology - Investing.com
Nuwellis Receives U.S. Patent for Dual Lumen Catheter for Extracorporeal Therapies - Quiver Quantitative
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies - The Manila Times
Nuwellis Catheter Design Lets Clinicians Trim Length for Patients - Stock Titan
NUWE Q1 2026 Earnings: Significant EPS Miss Amidst Stock Price IncreaseEarnings Beat Alert - dars.gov.et
Nuwellis names Mike McCormick as CEO - MSN
NUWE Q1 2026 Earnings: Massive EPS Miss as Company Reports No RevenueNegative Surprise Momentum - dars.gov.et
Form DEF 14A Nuwellis Inc For: 7 July By Investing.com - Investing.com Nigeria
Nuwellis (NASDAQ: NUWE) seeks warrant share and reverse split votes - Stock Titan
Nuwellis to showcase Aquadex therapy at KidneyB... - Pluang
Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 - The Manila Times
Nuwellis takes Aquadex to a pediatric kidney conference in Colorado - Stock Titan
Nuwellis Inc. (NUWE) Bounces From Support, Testing Resistance After 5.4% GainOption Breadth - dars.gov.et
NUWE Q1 2026 Earnings: Significant EPS Miss Highlights Persistent Cost PressuresBuyback Announcement Report - dars.gov.et
NUWENuwellis Inc Short Interest - Finviz
Nuwellis (NASDAQ: NUWE) CEO McCormick files initial insider Form 3 - Stock Titan
NUWE Q1 2026 Earnings: EPS Miss of 104.9% Sends Shares LowerNext Quarter Guidance - dars.gov.et
Nuwellis Inc (FRA:22S1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
CHF Solutions, Inc.Special Call Transcript - GuruFocus
Nuwellis Inc (FRA:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Revenue per share of Nuwellis, Inc. – FWB:22S1 - TradingView
Price to cash flow ratio of Nuwellis, Inc. – FWB:22S1 - TradingView
Average basic shares outstanding of Nuwellis, Inc. – FWB:22S1 - TradingView
Net income of Nuwellis, Inc. – FWB:22S1 - TradingView
NUWELL.INC.NEW26 DL-,0001 Financial Statements – FWB:22S1 - TradingView
Nuwellis, Inc. Income Statement – FWB:22S1 - TradingView
Enterprise value to EBITDA forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Q1 2026 Nuwellis Inc Earnings Call Transcript - GuruFocus
Price to earnings forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Price to book forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Nuwellis Inc (STU:22S1) DCF Valuation - GuruFocus
Nuwellis Inc (STU:22S1) Stock Price & 30 Year Financial Data - GuruFocus
Nuwellis Inc (STU:22S1) Stock Earnings Transcripts - GuruFocus
Enterprise value to revenue forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Enterprise value to EBIT forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Form PRE 14A Nuwellis Inc For: 26 June - Investing.com UK
Price to sales forward of Nuwellis, Inc. – NASDAQ:NUWE - TradingView
Form PRE 14A Nuwellis Inc For: 26 June By Investing.com - Investing.com Nigeria
0.79%
4.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):